Safilo Group S.p.A. (SAFLF)
USD 0.98
(0.0%)
USD 0.98
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -24.64 Million EUR | -145.51% |
| 2022 | 54.16 Million EUR | 154.57% |
| 2021 | 21.27 Million EUR | 129.16% |
| 2020 | -72.96 Million EUR | 77.77% |
| 2019 | -328.26 Million EUR | -911.71% |
| 2018 | -32.44 Million EUR | 87.1% |
| 2017 | -251.56 Million EUR | -77.03% |
| 2016 | -142.1 Million EUR | -169.41% |
| 2015 | -52.74 Million EUR | -235.14% |
| 2014 | 39.03 Million EUR | 151.47% |
| 2013 | 15.52 Million EUR | -39.99% |
| 2012 | 25.86 Million EUR | -7.17% |
| 2011 | 27.86 Million EUR | 510.47% |
| 2010 | 4.56 Million EUR | 101.3% |
| 2009 | -350.78 Million EUR | -1404.56% |
| 2008 | -23.31 Million EUR | -142.75% |
| 2007 | 54.54 Million EUR | 33.64% |
| 2006 | 40.81 Million EUR | 546.08% |
| 2005 | 6.31 Million EUR | -71.27% |
| 2004 | 21.98 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 18.85 Million USD | 0.0% |
| 2023 FY | -24.64 Million EUR | -145.51% |
| 2023 Q4 | -17.31 Million USD | -120.75% |
| 2023 Q3 | -7.84 Million EUR | 19.72% |
| 2023 Q2 | -9.77 Million USD | -118.15% |
| 2023 Q1 | -4.47 Million EUR | -119.52% |
| 2022 Q2 | 16.35 Million USD | 0.0% |
| 2022 Q4 | 22.94 Million USD | 114.05% |
| 2022 FY | 54.16 Million EUR | 154.57% |
| 2022 Q1 | 16.35 Million EUR | 69.39% |
| 2022 Q3 | 10.72 Million EUR | -34.46% |
| 2021 Q3 | 9.65 Million EUR | 885.46% |
| 2021 Q2 | 980 Thousand USD | 0.0% |
| 2021 FY | 21.27 Million EUR | 129.16% |
| 2021 Q1 | 980 Thousand EUR | 9.74% |
| 2021 Q4 | 9.65 Million USD | 0.0% |
| 2020 Q3 | 893 Thousand EUR | 102.39% |
| 2020 FY | -72.96 Million EUR | 77.77% |
| 2020 Q1 | -37.37 Million EUR | -36.05% |
| 2020 Q2 | -37.37 Million USD | 0.0% |
| 2020 Q4 | 893 Thousand USD | 0.0% |
| 2019 Q3 | -27.47 Million EUR | 90.86% |
| 2019 Q1 | -123.47 Million EUR | -1987.2% |
| 2019 FY | -328.26 Million EUR | -911.71% |
| 2019 Q2 | -300.55 Million EUR | -143.4% |
| 2019 Q4 | -27.47 Million USD | 0.0% |
| 2018 Q3 | -5.91 Million EUR | -49.39% |
| 2018 Q4 | -5.91 Million EUR | 0.0% |
| 2018 FY | -32.44 Million EUR | 87.1% |
| 2018 Q1 | -3.96 Million EUR | 96.73% |
| 2018 Q2 | -3.96 Million EUR | 0.0% |
| 2017 Q1 | -4.8 Million EUR | 93.94% |
| 2017 Q4 | -120.98 Million EUR | 0.0% |
| 2017 Q3 | -120.98 Million EUR | -2420.22% |
| 2017 FY | -251.56 Million EUR | -77.03% |
| 2017 Q2 | -4.8 Million EUR | 0.0% |
| 2016 FY | -142.1 Million EUR | -169.41% |
| 2016 Q2 | 8.15 Million EUR | 0.0% |
| 2016 Q4 | -79.2 Million EUR | 0.0% |
| 2016 Q3 | -79.2 Million EUR | -1071.25% |
| 2016 Q1 | 8.15 Million EUR | 112.83% |
| 2015 FY | -52.74 Million EUR | -235.14% |
| 2015 Q4 | -63.54 Million EUR | -2711.96% |
| 2015 Q3 | 2.43 Million EUR | -64.85% |
| 2015 Q2 | 6.92 Million EUR | 377.71% |
| 2015 Q1 | 1.44 Million EUR | -80.22% |
| 2014 Q1 | 16.46 Million EUR | 361.47% |
| 2014 Q4 | 7.32 Million EUR | 207.56% |
| 2014 Q3 | 2.38 Million EUR | -81.48% |
| 2014 Q2 | 12.86 Million EUR | -21.88% |
| 2014 FY | 39.03 Million EUR | 151.47% |
| 2013 FY | 15.52 Million EUR | -39.99% |
| 2013 Q2 | 6.69 Million EUR | -50.01% |
| 2013 Q4 | -6.29 Million EUR | -464.35% |
| 2013 Q1 | 13.39 Million EUR | 168.58% |
| 2013 Q3 | 1.72 Million EUR | -74.19% |
| 2012 Q1 | 11.94 Million EUR | 167.39% |
| 2012 Q3 | -646 Thousand EUR | -106.75% |
| 2012 Q4 | 4.98 Million EUR | 871.98% |
| 2012 FY | 25.86 Million EUR | -7.17% |
| 2012 Q2 | 9.57 Million EUR | -19.84% |
| 2011 Q2 | 13.95 Million EUR | -28.32% |
| 2011 Q4 | 4.46 Million EUR | 195.45% |
| 2011 FY | 27.86 Million EUR | 510.47% |
| 2011 Q3 | -4.68 Million EUR | -133.55% |
| 2011 Q1 | 19.46 Million EUR | 290.12% |
| 2010 Q2 | -4.34 Million EUR | -242.26% |
| 2010 FY | 4.56 Million EUR | 101.3% |
| 2010 Q3 | 866 Thousand EUR | 119.93% |
| 2010 Q1 | 3.05 Million EUR | 101.84% |
| 2010 Q4 | 4.98 Million EUR | 476.1% |
| 2009 Q1 | 2.13 Million EUR | 0.0% |
| 2009 FY | -350.78 Million EUR | -1404.56% |
| 2009 Q4 | -166.29 Million EUR | -232.77% |
| 2009 Q3 | -49.97 Million EUR | 63.6% |
| 2009 Q2 | -137.31 Million EUR | -6531.38% |
| 2008 FY | -23.31 Million EUR | -142.75% |
| 2007 FY | 54.54 Million EUR | 33.64% |
| 2006 FY | 40.81 Million EUR | 546.08% |
| 2005 FY | 6.31 Million EUR | -71.27% |
| 2004 FY | 21.98 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | -2559.315% |
| Ansell Limited | 76.5 Million USD | 132.221% |
| Ansell Limited | 76.5 Million USD | 132.221% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 201.519% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | -1411.983% |
| Psykey, Inc. | -1.32 Million USD | -1761.776% |
| ConvaTec Group Plc | 130.3 Million USD | 118.917% |
| ConvaTec Group Plc | 130.3 Million USD | 118.917% |
| Encision Inc. | -691.78 Thousand USD | -3463.112% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -17281.585% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | -10417.311% |
| Innovative MedTech Inc. | -7.93 Million USD | -210.484% |
| LifePoint, Inc. | -15.23 Million USD | -61.828% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | -261.9% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | -5100.211% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | -8881.366% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | -5269.825% |
| SmileDirectClub, Inc. | -86.4 Million USD | 71.472% |
| Sector 10, Inc. | 7036.00 USD | 350426.89% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 101.231% |
| SheerVision, Inc. | -71.37 Thousand USD | -34434.017% |
| United Health Products, Inc. | -2.62 Million USD | -839.63% |
| Vasamed, Inc. | -4.88 Million USD | -404.26% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | -932.001% |
| Yubo International Biotech Limited | -1.2 Million USD | -1945.959% |